TREA

79352300 - VECTRON

Follow

Information

  • Trademark
  • 79352300
  • Serial Number
    79352300
  • Registration Number
    7376435
  • Filing Date
    August 01, 2022
    2 years ago
  • Registration Date
    May 07, 2024
    11 months ago
  • Transaction Date
    November 23, 2024
    4 months ago
  • Status Date
    May 07, 2024
    11 months ago
  • Published for Opposition Date
    February 20, 2024
    a year ago
  • Location Date
    May 06, 2024
    11 months ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    STEEL, ALYSSA
  • Attorney Docket Number
    19250-0466
    Attorney Name
    Douglas T. Johnson
    Law Office Assigned Location Code
    N60
  • Owners
Information
Mark Drawing Code
4
Mark Identification
VECTRON
Case File Statements
  • GS0051: Viral systems comprised of viral vectors combined with antibodies; gene therapy systems comprised of viral vectors combined with antibodies; nucleic acid delivery systems being therapeutic agents for delivery to human tissue namely viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors for medical purposes; pharmaceutical products for the treatment of neuro degenerative and neuromuscular disorders being autoimmune diseases; biological preparations for the treatment neuro degenerative and neuromuscular disorders being autoimmune diseases; biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy and cell therapy for the treatment of neuro degenerative and neuromuscular disorders being autoimmune diseases; clinical medical reagents for use in nucleic acid-based therapy, cell therapy, pharmaceutical preparations, prophylaxis products preparations and other pharmaceutical products preparations and other pharmaceutical products preparations for use in nucleic acid-based therapy, gene therapy for the treatment of neuro degenerative and neuromuscular disorders being autoimmune diseases
  • GS0441: Medical treatment by gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; consultancy in the field of pharmaceutics
  • GS0421: Scientific and medical research, product development and consultancy in the field of biotechnology, biologics, medical science, chemistry and biochemistry; Scientific and medical research and product development in the field of pharmaceutics
Case File Event Statements
  • 10/18/2022 - 2 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 10/13/2022 - 2 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 10/14/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 4/11/2023 - 2 years ago
    4 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 5/18/2023 - a year ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/19/2023 - a year ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 5/20/2023 - a year ago
    7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 6/27/2023 - a year ago
    8 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 6/27/2023 - a year ago
    9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 7/22/2023 - a year ago
    10 - REFUSAL PROCESSED BY IB Type: RFNT
  • 12/7/2023 - a year ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/7/2023 - a year ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/8/2023 - a year ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/12/2023 - a year ago
    14 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 12/12/2023 - a year ago
    15 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 12/12/2023 - a year ago
    16 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 12/12/2023 - a year ago
    17 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 1/2/2024 - a year ago
    19 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR
  • 12/18/2023 - a year ago
    18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/2/2024 - a year ago
    20 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR
  • 1/31/2024 - a year ago
    21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/7/2024 - a year ago
    22 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 2/7/2024 - a year ago
    23 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 2/20/2024 - a year ago
    24 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/26/2024 - a year ago
    25 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 3/4/2024 - a year ago
    26 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/13/2024 - a year ago
    27 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 3/13/2024 - a year ago
    28 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 4/1/2024 - a year ago
    29 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 5/7/2024 - 11 months ago
    30 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 5/7/2024 - 11 months ago
    31 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 8/7/2024 - 8 months ago
    32 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 10/31/2024 - 5 months ago
    34 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 11/23/2024 - 4 months ago
    35 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 10/31/2024 - 5 months ago
    33 - FINAL DISPOSITION PROCESSED Type: FIMP